Supernus Pharmaceuticals, Inc. / Financial strength (Piotroski F-Value)

    The F-Value, developed by Stanford accounting professor Joseph Piotroski, measures a company's financial strength based on nine distinct criteria. Piotroski suggest using the value as part of a value investing strategy to rank stocks with a low price-to-book ratio. The approach is described in detail in Piotroski's 2002 Paper Value Investing: The Use of Historical Financial Statement Information to Separate Winners From Losers.

    Financial strength (Piotroski F-Value)
    7 / 9
    Return on assets (ROA) greater than 0
    check 4.7%
    Operating cash flow greater than 0
    check $159.55M
    ROA greater than previous year
    check 4.7% > 0.4%
    Cash flow return on assets (CFROA) greater than Return on assets (ROA)
    check 13.5% > 4.7%
    Leverage ratio lower than previous year
    close 3.5% ≥ 2.3%
    Current ratio greater than previous year
    check 258.0% > 191.5%
    No new common stock issued last year
    close $13.35M
    Gross margin greater than previous year
    check 79.5% > 78.3%
    Asset turnover greater than previous year
    check 48.1% > 47.9%

    F-Value history

    The F-Value is calculated for each quarter based on the cumulation of the previous four quarterly statements. Click on the chart to see the F-Value at a specific time in the past.

    6
    4
    5
    3
    3
    2
    3
    3
    4
    7
    7
    7
    5
    4
    4
    4
    5
    5
    5
    6
    5
    5
    5
    5
    5
    5
    6
    5
    5
    4
    5
    4
    4
    5
    5
    6
    6
    4
    4
    6
    6
    6
    5
    5
    5
    5
    4
    5
    7
    7
    7
    7

    Notifications